Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.

Evaluate the effectiveness and safety of traditional Chinese medicine compound in improving radiotherapy-induced oral mucositis in patients with head and neck malignant tumors.

Trial Details

NCT ID
NCT07339774
Phase
PHASE2
Sponsor
West China Hospital
Status
RECRUITING
Cancer Type
Nasopharyngeal Head and Neck Cancer
Interventions
  • Placebo oral liquid and mouthwash
  • Zishui Daohuo oral liquid combined with Kujiu mouthwash
  • Radiotherapy
Locations (sample)
  • Chengdu, Sichuan, China|30.66667,104.06667

Key Eligibility Criteria

  • Patients pathologically diagnosed with non-metastatic head and neck malignant tumors;
  • Age range: 18 to 65 years old (including 18 and 65 years old);
  • Eastern Cooperative Oncology Group performance status of ≤2;
  • Radiotherapy or concurrent chemoradiotherapy is required;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Nasopharyngeal Head and Neck Cancer Trials on Trialify →